Literature DB >> 28925749

Cardiac telerehabilitation: A novel cost-efficient care delivery strategy that can induce long-term health benefits.

Ines Frederix1,2,3, Francesca Solmi4, Massimo F Piepoli5, Paul Dendale1,2.   

Abstract

Background Finding innovative and cost-efficient care strategies that induce long-term health benefits in cardiac patients constitutes a big challenge today. The aim of this Telerehab III follow-up study was to assess whether a 6-month additional cardiac telerehabilitation programme could induce long-term health benefits and remain cost-efficient after the tele-intervention ended. Methods and results A total of 126 cardiac patients first completed the multicentre, randomised controlled telerehabilitation trial (Telerehab III, time points t0 to t1). They consequently entered the follow-up study (t1) with evaluations 2 years later (t2). A quantitative analysis of peak aerobic capacity (VO2 peak, primary endpoint), international physical activity questionnaire self-reported physical activity and HeartQoL quality of life (secondary endpoints) was performed. The incremental cost-effectiveness ratio was calculated. Even though a decline in VO2 peak (24 ± 8 ml/[min*kg] at t1 and 22 ± 6 ml/[min*kg] at t2; P ≤ 0.001) was observed within the tele-intervention group patients; overall they did better than the no tele-intervention group ( P = 0.032). Dividing the incremental cost (-€878/patient) by the differential incremental quality-adjusted life years (QALYs) (0.22 QALYs) yielded an incremental cost-effectiveness ratio of -€3993/QALY. Conclusions A combined telerehabilitation and centre-based programme, followed by transitional telerehabilitation induced persistent health benefits and remained cost-efficient up to 2 years after the end of the intervention. A partial decline of the benefits originally achieved did occur once the tele-intervention ended. Healthcare professionals should reflect on how innovative cost-efficient care models could be implemented in standard care. Future research should focus on key behaviour change techniques in technology-based interventions that enable full persistence of long-term behaviour change and health benefits. This study is registered in the ISRCTN registry (ISRCTN29243064).

Entities:  

Keywords:  Telerehabilitation; cardiac rehabilitation; cost-effectiveness; eHealth; rehabilitation; telemedicine

Mesh:

Year:  2017        PMID: 28925749     DOI: 10.1177/2047487317732274

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN: 2047-4873            Impact factor:   7.804


  20 in total

Review 1.  Towards Optimized Care After Bariatric Surgery by Physical Activity and Exercise Intervention: a Review.

Authors:  Dominique Hansen; Lieselot Decroix; Yves Devos; David Nocca; Veronique Cornelissen; Bruno Dillemans; Matthias Lannoo
Journal:  Obes Surg       Date:  2020-03       Impact factor: 4.129

2.  Recommendations on the utilization of telemedicine in cardiology.

Authors:  Michael Gruska; Gerhard Aigner; Johann Altenberger; Dagmar Burkart-Küttner; Lukas Fiedler; Marianne Gwechenberger; Peter Lercher; Martin Martinek; Michael Nürnberg; Gerhard Pölzl; Gerold Porenta; Stefan Sauermann; Christoph Schukro; Daniel Scherr; Clemens Steinwender; Markus Stühlinger; Alexander Teubl
Journal:  Wien Klin Wochenschr       Date:  2020-12-01       Impact factor: 1.704

3.  Efficacy, efficiency and safety of a cardiac telerehabilitation programme using wearable sensors in patients with coronary heart disease: the TELEWEAR-CR study protocol.

Authors:  Varsamo Antoniou; Andrew Xanthopoulos; Gregory Giamouzis; Constantinos Davos; Ladislav Batalik; Vasileios Stavrou; Konstantinos I Gourgoulianis; Eleni Kapreli; John Skoularigis; Garyfallia Pepera
Journal:  BMJ Open       Date:  2022-06-23       Impact factor: 3.006

Review 4.  Physical Activity in the Prevention and Treatment of Coronary Artery Disease.

Authors:  Ephraim Bernhard Winzer; Felix Woitek; Axel Linke
Journal:  J Am Heart Assoc       Date:  2018-02-08       Impact factor: 5.501

5.  Rationale and design of randomized controlled trial protocol of cardiovascular rehabilitation based on the use of telemedicine technology in the Czech Republic (CR-GPS).

Authors:  Ladislav Batalik; Filip Dosbaba; Martin Hartman; Katerina Batalikova; Jindrich Spinar
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

6.  Evaluating the Impact of the HeartHab App on Motivation, Physical Activity, Quality of Life, and Risk Factors of Coronary Artery Disease Patients: Multidisciplinary Crossover Study.

Authors:  Supraja Sankaran; Paul Dendale; Karin Coninx
Journal:  JMIR Mhealth Uhealth       Date:  2019-04-04       Impact factor: 4.773

7.  Effects and costs of real-time cardiac telerehabilitation: randomised controlled non-inferiority trial.

Authors:  Ralph Maddison; Jonathan Charles Rawstorn; Ralph A H Stewart; Jocelyne Benatar; Robyn Whittaker; Anna Rolleston; Yannan Jiang; Lan Gao; Marj Moodie; Ian Warren; Andrew Meads; Nicholas Gant
Journal:  Heart       Date:  2018-08-27       Impact factor: 5.994

8.  MI-PACE Home-Based Cardiac Telerehabilitation Program for Heart Attack Survivors: Usability Study.

Authors:  Eric Y Ding; Nathaniel Erskine; Wim Stut; David D McManus; Amy Peterson; Ziyue Wang; Jorge Escobar Valle; Daniella Albuquerque; Alvaro Alonso; Naomi F Botkin; Quinn R Pack; David D McManus
Journal:  JMIR Hum Factors       Date:  2021-07-08

9.  Assessment of Physical Activity by Wearable Technology During Rehabilitation After Cardiac Surgery: Explorative Prospective Monocentric Observational Cohort Study.

Authors:  Isabeau Thijs; Libera Fresiello; Wouter Oosterlinck; Peter Sinnaeve; Filip Rega
Journal:  JMIR Mhealth Uhealth       Date:  2019-01-31       Impact factor: 4.773

10.  Smartphone Cardiac Rehabilitation, Assisted Self-Management Versus Usual Care: Protocol for a Multicenter Randomized Controlled Trial to Compare Effects and Costs Among People With Coronary Heart Disease.

Authors:  Jonathan Charles Rawstorn; Kylie Ball; Brian Oldenburg; Clara K Chow; Sarah A McNaughton; Karen Elaine Lamb; Lan Gao; Marj Moodie; John Amerena; Voltaire Nadurata; Christopher Neil; Stuart Cameron; Ralph Maddison
Journal:  JMIR Res Protoc       Date:  2020-01-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.